Addus HomeCare (ADUS) News Today

Addus HomeCare (ADUS) is trading lower today. Investors are weighing a mixed Q1 report — an earnings-per-share beat but a revenue miss — alongside news of small-market acquisitions and ongoing analyst/valuation debate. Below are the key items that likely explain the stock move and what to watch next.

• Positive Sentiment: Q1 EPS beat consensus ($1.62 vs. $1.52) and year-over-year EPS growth; profitability metrics (net margin, ROE) were highlighted on the call, supporting earnings quality. Addus HomeCare (ADUS) Q1 Earnings Top Estimates
• Positive Sentiment: Strategic M&A: Addus announced entry into Indiana via the HomeCourt acquisition and signaled another pending deal — expands geographic footprint and revenue runway in homecare markets. M&A should support long-term growth if integrations perform. Addus Enters Indiana With HomeCourt Acquisition, Lines Up Second Deal
• Positive Sentiment: Earnings-call takeaways emphasize “profitable growth” and personal-care strength even as some volumes were flat — management framing growth as margin-accretive. That narrative can support multiple expansion if sustained. Addus HomeCare Earnings Call Highlights Profitable Growth
• Positive Sentiment: Analyst view: Citizens Jmp trimmed its price target to $142 (from $150) but maintained a "market outperform" rating — shows continued analyst confidence and meaningful upside from current levels. Benzinga note on price target
• Neutral Sentiment: Investor access: management scheduled presentations at BofA health-care conference in mid-May — expect additional color on 2026 outlook and M&A strategy that could move consensus. Addus HomeCare to Participate in Upcoming Investor Conferences in May
• Neutral Sentiment: Full earnings-call transcript and deeper analyses are available (useful for checking guidance details and segment trends). Addus HomeCare Q1 2026 Earnings Call Transcript
• Neutral Sentiment: Valuation debate: recent pieces revisit DCF/valuation gaps after the quarter — these analyses could amplify swings as investors reassess upside vs. execution risk. A Look At Addus HomeCare (ADUS) Valuation After Q1 Earnings Beat And Indiana Acquisitions
• Negative Sentiment: Revenue miss: Q1 sales of $363.5M fell short of Street expectations (~$366.4M), which markets cited as the primary trigger for the share decline despite the EPS beat. Addus HomeCare (NASDAQ:ADUS) Misses Q1 CY2026 Sales Expectations
• Negative Sentiment: Market reaction coverage explains the drop: headlines point to the revenue miss and mixed operational signals (flat volumes in some lines) as reasons sellers stepped in. Why Addus HomeCare (ADUS) shares are trading lower today